MS Trust Archives -

NICE has reversed its decision not to approve a new drug that offers hope to thousands of people

Addressing MS’ two-tier healthcare system is about ‘social justice’

https://pharmaphorum.com/views-analysis-patients/ms-two-tier-healthcare-system/

The success or failure of patient centricity rests on getting the patient voice in the mix – not

Listening to the Patient Voice: seek out the quietest voice to meet the biggest need

https://pharmaphorum.com/views-analysis-patients/listening-patient-voice/

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care. But

Case study: Ensuring safety by digitally linking prescription management to blood monitoring

https://pharmaphorum.com/views-analysis-digital/ms-case-study-safety-digitally-linking-prescription-management/

Jo Sopala of the MS Trust describes the organisation’s work in creating better multiple sclerosis care.

Addressing the growing need for better Multiple Sclerosis care

https://pharmaphorum.com/views-and-analysis/addressing-growing-need-better-multiple-sclerosis-care/

MS Trust